MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer

Overview of attention for article published in Journal of Hematology & Oncology, June 2019

Altmetric Badge

Mentioned by

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 2,972 followers.

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer https://t.co/XsMSsWsuMb

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer https://t.co/XsMSsWsuMb

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer https://t.co/XsMSsWsuMb

Review | An overview of MET inhibitors for targeted therapy of EGFR TKI-resistant #LungCancer. @WinshipAtEmory https://t.co/iYdW80gEZU

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.